Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Clinical trial NCT03922724 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03922724
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphomas Lymphoproliferative Disorders Immune System Diseases

Start date: 2019-04-18
Primary completion: 2027-06-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.